584 related articles for article (PubMed ID: 24440439)
41. Out-of-range INR values and outcomes among new warfarin patients with non-valvular atrial fibrillation.
Nelson WW; Wang L; Baser O; Damaraju CV; Schein JR
Int J Clin Pharm; 2015 Feb; 37(1):53-9. PubMed ID: 25428444
[TBL] [Abstract][Full Text] [Related]
42. Lower-dose warfarin delays renal progression and prolongs patient survival in patients with stage 3 - 5 chronic kidney disease and nonvalvular atrial fibrillation: a 12-year follow-up study.
Chiu PF; Huang CH; Liou HH; Wu CL; Chang C; Chang CC; Chang HR
Int J Clin Pharmacol Ther; 2014 Jun; 52(6):504-8. PubMed ID: 24755133
[TBL] [Abstract][Full Text] [Related]
43. [Atrial fibrillation and stroke].
Mattle HP; Schwerzmann M; Seiler Ch
Ther Umsch; 2003 Sep; 60(9):527-34. PubMed ID: 14579621
[TBL] [Abstract][Full Text] [Related]
44. Bleeding risk with triple antithrombotic therapy in patients with atrial fibrillation and drug-eluting stents.
Enomoto Y; Iijima R; Tokue M; Ito N; Nagashima Y; Araki T; Yamazaki K; Utsunomiya M; Hori M; Itaya H; Shiba M; Hara H; Nakamura M; Sugi K
Cardiovasc Interv Ther; 2014 Jul; 29(3):193-9. PubMed ID: 24366503
[TBL] [Abstract][Full Text] [Related]
45. Anticoagulation in women with non-valvular atrial fibrillation in the stroke prevention using an oral thrombin inhibitor (SPORTIF) trials.
Gomberg-Maitland M; Wenger NK; Feyzi J; Lengyel M; Volgman AS; Petersen P; Frison L; Halperin JL
Eur Heart J; 2006 Aug; 27(16):1947-53. PubMed ID: 16774980
[TBL] [Abstract][Full Text] [Related]
46. Relationship between platelet indices and international normalized ratio in patients with non-valvular atrial fibrillation.
Arık OZ; Ozkan B; Kutlu R; Karal H; Sahin DY; Kaypaklı O; Ozel D; Cayli M
Platelets; 2014; 25(5):311-6. PubMed ID: 23971881
[TBL] [Abstract][Full Text] [Related]
47. Warfarin in atrial fibrillation patients with moderate chronic kidney disease.
Hart RG; Pearce LA; Asinger RW; Herzog CA
Clin J Am Soc Nephrol; 2011 Nov; 6(11):2599-604. PubMed ID: 21903982
[TBL] [Abstract][Full Text] [Related]
48. Determinants of warfarin use and international normalized ratio levels in atrial fibrillation patients in Japan. - Subanalysis of the J-RHYTHM Registry-.
J-RHYTHM Registry Investigators
Circ J; 2011; 75(10):2357-62. PubMed ID: 21791869
[TBL] [Abstract][Full Text] [Related]
49. The predictive ability of the CHADS2 and CHA2DS2-VASc scores for bleeding risk in atrial fibrillation: the MAQI(2) experience.
Barnes GD; Gu X; Haymart B; Kline-Rogers E; Almany S; Kozlowski J; Besley D; Krol GD; Froehlich JB; Kaatz S
Thromb Res; 2014 Aug; 134(2):294-9. PubMed ID: 24929840
[TBL] [Abstract][Full Text] [Related]
50. Relationship of the SAMe-TT₂R₂ score to poor-quality anticoagulation, stroke, clinically relevant bleeding, and mortality in patients with atrial fibrillation.
Lip GYH; Haguenoer K; Saint-Etienne C; Fauchier L
Chest; 2014 Sep; 146(3):719-726. PubMed ID: 24722973
[TBL] [Abstract][Full Text] [Related]
51. Fixed minidose warfarin and aspirin alone and in combination vs adjusted-dose warfarin for stroke prevention in atrial fibrillation: Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulation Study.
Gulløv AL; Koefoed BG; Petersen P; Pedersen TS; Andersen ED; Godtfredsen J; Boysen G
Arch Intern Med; 1998 Jul; 158(14):1513-21. PubMed ID: 9679792
[TBL] [Abstract][Full Text] [Related]
52. Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: the AFASAK 2 study. Atrial Fibrillation Aspirin and Anticoagulation.
Gulløv AL; Koefoed BG; Petersen P
Arch Intern Med; 1999 Jun; 159(12):1322-8. PubMed ID: 10386508
[TBL] [Abstract][Full Text] [Related]
53. Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation : a multicenter, prospective, randomized trial. Japanese Nonvalvular Atrial Fibrillation-Embolism Secondary Prevention Cooperative Study Group.
Yamaguchi T
Stroke; 2000 Apr; 31(4):817-21. PubMed ID: 10753981
[TBL] [Abstract][Full Text] [Related]
54. Preprocedural therapeutic international normalized ratio influence on bleeding complications in atrial fibrillation ablation with continued anticoagulation with warfarin.
Hayashi T; Kumagai K; Naito S; Goto K; Kaseno K; Ohshima S; Hachiya H; Hirao K; Isobe M
Circ J; 2013; 77(2):338-44. PubMed ID: 23090638
[TBL] [Abstract][Full Text] [Related]
55. Incidence of major bleeding complication of warfarin therapy in Japanese patients with atrial fibrillation.
Suzuki S; Yamashita T; Kato T; Fujino T; Sagara K; Sawada H; Aizawa T; Fu LT
Circ J; 2007 May; 71(5):761-5. PubMed ID: 17457005
[TBL] [Abstract][Full Text] [Related]
56. Can early effective anticoagulation prevent new lesions on magnetic resonance imaging in acute cardioembolic stroke?
Nomura E; Ohshita T; Imamura E; Wakabayashi S; Kajikawa H; Matsumoto M
J Stroke Cerebrovasc Dis; 2014 Sep; 23(8):2099-2104. PubMed ID: 25106835
[TBL] [Abstract][Full Text] [Related]
57. Meta-analysis of efficacy and safety of the new anticoagulants versus warfarin in patients with atrial fibrillation.
Jia B; Lynn HS; Rong F; Zhang W
J Cardiovasc Pharmacol; 2014 Oct; 64(4):368-74. PubMed ID: 24869601
[TBL] [Abstract][Full Text] [Related]
58. Prevention of thromboembolism in patients with mitral stenosis and associated atrial fibrillation: effectiveness of low intensity (INR target 2) oral anticoagulant treatment.
Pengo V; Barbero F; Biasiolo A; Pegoraro C; Noventa F; Iliceto S
Thromb Haemost; 2003 Apr; 89(4):760-4. PubMed ID: 12669133
[TBL] [Abstract][Full Text] [Related]
59. Time outside of therapeutic range in atrial fibrillation patients is associated with long-term risk of dementia.
Jacobs V; Woller SC; Stevens S; May HT; Bair TL; Anderson JL; Crandall BG; Day JD; Johanning K; Long Y; Mallender C; Olson JL; Osborn JS; Weiss JP; Bunch TJ
Heart Rhythm; 2014 Dec; 11(12):2206-13. PubMed ID: 25111326
[TBL] [Abstract][Full Text] [Related]
60. Effects of fixed low-dose warfarin, aspirin-warfarin combination therapy, and dose-adjusted warfarin on thrombogenesis in chronic atrial fibrillation.
Li-Saw-Hee FL; Blann AD; Lip GY
Stroke; 2000 Apr; 31(4):828-33. PubMed ID: 10753983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
